Asklepios Hospital Barmbek
Asklepios Hospital Barmbek
Germany, Hamburg
Axel Stang
30 anni di esperienza
accreditamenti :
Clinica certificata da :
The cost of immunotherapy with Keytruda (pembrolizumab) in Germany typically ranges from $10,000 to $15,000. Prices depend on the dosage, number of treatment cycles, the hospital, and whether additional diagnostics or supportive therapies are needed. In the United States, the average cost is $21,500 (per NCCN). Immunotherapy with Keytruda in Germany is about 42% less expensive than in the U.S.
German hospitals usually include the medication, infusion sessions, pre-treatment blood tests, physician monitoring, and follow-up visits in the package. In the U.S., the listed price often covers only the drug itself, with separate charges for administration, lab work, and ongoing care. Patients should always confirm which services and support are included at each clinic.
Why choose Germany for immunotherapy with Keytruda (Pembrolizumab)?
Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics .
| Germany | Turchia | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | da $10,000 | da $3,300 | da $15,000 |
Revisionato medicalmente da
Fahad MawloodAs the leading global medical tourism platform, we have a huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Dr. Buhl specializes in treating brain metastases and vascular anomalies, combining clinical expertise with groundbreaking research.
Dr. Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.
Professor Axel Stang leads the oncology department at Asklepios Barmbek Clinic, specializing in advanced antibody and molecular therapies for tumors.
Prof. Dr. med. Karl J. Oldhafer specializes in pancreatic, liver, and stomach cancer, leading the Department of General and Abdominal Surgery at Asklepios Hospital Barmbek.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.